Cofrogliptin (HSK7653)(compound 2)

Modify Date: 2024-01-03 01:57:32

Cofrogliptin (HSK7653)(compound 2) Structure
Cofrogliptin (HSK7653)(compound 2) structure
Common Name Cofrogliptin (HSK7653)(compound 2)
CAS Number 1844874-26-5 Molecular Weight 466.43
Density N/A Boiling Point N/A
Molecular Formula C18H19F5N4O3S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Cofrogliptin (HSK7653)(compound 2)


Cofrogliptin (HSK7653) (compound 2), a tetrahydropyran derivative, is a potent oral dipeptidyl aminopeptidase 4 (DPP-4) inhibitor with Long-acting antidiabetic efficacy. Cofrogliptin (compound 2) has a great potential for type 2 diabetes mellitus (T2DM) [1].

 Names

Name D-arabino-Hexitol, 5-amino-2,6-anhydro-1,3,4,5-tetradeoxy-6-C-(2,5-difluorophenyl)-3-[2,6-dihydro-2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(4H)-yl]-1,1,1-trifluoro-, (6R)-
Synonym More Synonyms

 Cofrogliptin (HSK7653)(compound 2) Biological Activity

Description Cofrogliptin (HSK7653) (compound 2), a tetrahydropyran derivative, is a potent oral dipeptidyl aminopeptidase 4 (DPP-4) inhibitor with Long-acting antidiabetic efficacy. Cofrogliptin (compound 2) has a great potential for type 2 diabetes mellitus (T2DM) [1].
Related Catalog
Target

IC50: 4.18 nM (DPP-4) [2]

In Vitro Cofrogliptin (HSK7653) (compound 2) has the DPP-4 inhibitory activity with an IC50 value of 4.18 nM[2].
References

[1]. International Nonproprietary Names for Pharmaceutical Substances (INN)

[2]. Chen Zhang, et al. Design, Synthesis, and Evaluation of a Series of Novel Super Long-Acting DPP-4 Inhibitors for the Treatment of Type 2 Diabetes. J Med Chem. 2020 Jul 9;63(13):7108-7126.

 Chemical & Physical Properties

Molecular Formula C18H19F5N4O3S
Molecular Weight 466.43

 Synonyms

Cofrogliptin (HSK7653) (compound 2)